Advisor Group Holdings, Inc. Pro Qr Therapeutics N.V. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 12,050 shares of PRQR stock, worth $28,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,050
Previous 7,250
66.21%
Holding current value
$28,679
Previous $14,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PRQR
# of Institutions
63Shares Held
41.2MCall Options Held
26KPut Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA6.6MShares$15.7 Million0.02% of portfolio
-
Privium Fund Management B.V.5MShares$11.9 Million1.92% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.5MShares$8.33 Million1.2% of portfolio
-
Morgan Stanley New York, NY3.08MShares$7.34 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.08MShares$4.94 Million2.02% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $170M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...